MEG3 and breast carcinoma: In summary, we have identified five novel lncRNAs (AL117190.1, COL4A2‐AS1, LINC00184, MEG3 and MIR22HG) related to prognosis of breast cancer, which could act as underlying prognosis biomarkers for breast cancer.